m+Medelevator.RU
← Поиск публикаций
Ultrasound in medicine & biology · 2026

Low-Intensity Pulsed Ultrasound (LIPUS) Mitigates Exercise-Induced Myocardial Fatigue by Optimizing Glucose Oxidation Via the Aldolase/AMPK/PDH Signaling Axis.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Liu Xindong, Liu Yuting, Gao Yushuo, Yi Ziyi, Zhao Nannan, Cai Hua, Li Min, Xu Lin

Аннотация

BACKGROUND: Myocardial energy deficiency is a key bottleneck limiting exercise endurance. Low-intensity pulsed ultrasound (LIPUS) has emerged as a non-invasive metabolic regulator. This study investigates whether LIPUS can activate glucose-centric pathways to alleviate exercise-induced myocardial fatigue.

METHODS: Sprague-Dawley rats were subjected to a 4-week exhaustive swimming protocol. LIPUS (1 MHz, 30 mW/cm², 20% duty cycle) was administered precordially for 30 min/day. We assessed exercise tolerance, cardiac injury markers (cTnI, NT-proBNP), mitochondrial ultrastructure, and metabolic flux. The activation of the Aldolase/AMPK/PDH axis was evaluated via Western blot and qPCR.

RESULTS: LIPUS treatment significantly prolonged exhaustive swimming time and reduced serum injury markers. Ultrastructural analysis revealed preserved mitochondrial cristae and myofiber alignment in LIPUS-treated hearts. Mechanistically, LIPUS promoted a metabolic switch from anaerobic glycolysis to efficient glucose aerobic oxidation by upregulating Aldolase and p-AMPK while reducing inhibitory PDH phosphorylation. Mitochondrial TCA cycle and respiratory chain activities (Complexes I-IV) were systematically restored.

CONCLUSIONS: LIPUS enhances myocardial glucose oxidation efficiency and exercise endurance by activating the Aldolase/AMPK/PDH signaling axis. These findings highlight LIPUS as a promising non-pharmacological strategy for exercise-induced cardioprotection.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты